Luca Arecco, MD
Enriched profileResearch Fellow, Jules Bordet Institute · Institut Jules Bordet (Brussels)
Luca Arecco is Research Fellow, Jules Bordet Institute at Institut Jules Bordet (Brussels). OpenAlex indexes 112 publications with 1,383 citations (h-index 23).
Data verified 9 Nov 2026
Overview
Updated 17 Nov 2026
Luca Arecco is Research Fellow, Jules Bordet Institute at Institut Jules Bordet (Brussels). The public record shows 112 publications with 1,383 citations (h-index 23), centered on Breast Cancer Treatment Studies, BRCA gene mutations in cancer, Reproductive Biology and Fertility.
- Most recent indexed publication: 2026 · Journal of the National Cancer Institute
- Top research focus: Breast Cancer Treatment Studies
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 20 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 31.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
Federally funded research awards.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 9 Nov 2026
20 congress contributions (2021–2026) across AACR, ASCO, ESHRE Annual Meeting, ESMO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 9 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.
Journal of the National Cancer Institute
Article2026 - Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship.
Therapeutic advances in medical oncology
Review2025 - Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies.
Human reproduction (Oxford, England)
Review2025
Congress posts on X
Post links from an X account tied to this person through reviewed identity evidence.
Listed under ASCO 2026
Listed under ASCO 2026
Listed under ASCO 2026
These links cover selected congress pages. They do not establish attendance or a complete posting history. Post availability may change.
Online presence
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- X / Twitter
x.com/lucarecco
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 9 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →breastcancerinyoungwomen.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
Secondary affiliations
appointments beyond the home institution- Medical Oncology resident
Clinical Oncology Unit, IRCCS Ospedale Policlinico San Martino, University of Genoa (Genoa, Italy)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →breastcancerinyoungwomen.org ↗ - Academic Trials Promoting Team
Institut Jules Bordet, with Hôpital Universitaire de Bruxelles (HUB)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →breastcancerinyoungwomen.org ↗ - Doctorate Student / Research Assistant
Laboratory of Clinical Cell Therapy, Jules Bordet Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →loop.frontiersin.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Norman Wolmark, MD
University of Pittsburgh
Hope Rugo, MD
City of Hope